Teleflex's (NYSE: TFX) fourth-quarter 2024 earnings conference call, held on February 27, 2025, revealed significant ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to ...

Teleflex management announced a significant acquisition and business split, but the market reacted negatively. Read why I ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex will acquire Biotronik's Vascular Intervention business for €760 million. Every week, our Whisper Index uncovers ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

In a flurry of news releases on Feb. 27, Teleflex Inc. reported plans to buy the vascular intervention business of Biotronik ...

Medical devices provider, Teleflex (NYSE:TFX) said on Thursday that it will acquire all of the vascular intervention business ...

Teleflex (TFX) announced it has entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of ...

In addition, Teleflex said it agreed to pay about 760 million euros (about $791 million) to acquire nearly all of Biotronik’s vascular intervention division. The company also announced the ...